MHRA Drug & Device Safety Alerts

Safety alerts, recalls, and field safety notices from the Medicines and Healthcare products Regulatory Agency — covering drug safety updates, medical device alerts, and class recalls.

514
Total Alerts
250
Drug Safety Updates
264
Device Alerts

Alerts by Type

Key Insights

514 MHRA alerts tracked. 250 Drug Safety Updates. 264 Medical Device Alerts.

MHRA alerts link to NHS trusts and healthcare bodies — cross-reference with responsible body scorecard pages to surface patterns between safety alert volumes and inquiry recommendation delivery.

Showing 514 alerts

Field Safety Notices: 6 to 10 April 2026
field-safety-notices-6-to-10-april-2026 Medical Device Alert
13 Apr 2026 MHRA
Field Safety Notices: 30 March - 3 April 2026
field-safety-notices-30-march-3-april-2026 Medical Device Alert
08 Apr 2026 MHRA
MHRA Safety Roundup: March 2026
mhra-safety-roundup-march-2026 Medical Device Alert
31 Mar 2026 MHRA
Field Safety Notices: 23-27 March 2026
field-safety-notices-23-27-march-2026 Medical Device Alert
31 Mar 2026 MHRA
Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injec…
class-2-medicines-recall-bio-products-laboratory-limited-rabies-human-normal-immunoglobulin-500iu-so Medical Device Alert
30 Mar 2026 MHRA
Class 4 Medicines Defect Notification: Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets ,…
class-4-medicines-defect-notification-quadrant-pharmaceuticals-limited-vesomni-6-mg-slash-0-dot-4-mg Medical Device Alert
26 Mar 2026 MHRA
Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17
class-4-medicines-defect-notification-sandoz-limited-apixaban-2-dot-5mg-and-5mg-tablets-el-26-a-slas Medical Device Alert
26 Mar 2026 MHRA
Field Safety Notices: 16 - 20 March 2026
field-safety-notices-16-20-march-2026 Medical Device Alert
24 Mar 2026 MHRA
Class 2 Medicines Recall: Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml, EL(26)A/15
class-2-medicines-recall-regent-medical-limited-slash-molnlycke-health-care-hibiwash-500ml-el-26-a-s Medical Device Alert
23 Mar 2026 MHRA
Field Safety Notices: 9 - 13 March 2026
field-safety-notices-9-13-march-2026 Medical Device Alert
17 Mar 2026 MHRA
Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone Injection 2 mg/ml concentrate for solut…
class-4-medicines-defect-notification-baxter-healthcare-corporation-onkotrone-injection-2-mg-slash-m Medical Device Alert
17 Mar 2026 MHRA
Class 3 Medicines Recall: Bayer Plc, Various Products, EL(26)A/12
class-3-medicines-recall-bayer-plc-various-products-el-26-a-slash-12 Medical Device Alert
12 Mar 2026 MHRA
Class 2 Medicines Recall: Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD …
class-2-medicines-recall-rokshaw-limited-trading-as-curaleaf-laboratories-curaleaf-oil-fs-10mg-slash Medical Device Alert
12 Mar 2026 MHRA
Field Safety Notices: 02 to 06 March 2026
field-safety-notices-02-to-06-march-2026 Medical Device Alert
09 Mar 2026 MHRA
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 5mg capsules, EL(26)A/11
class-2-medicines-recall-crescent-pharma-limited-ramipril-5mg-capsules-el-26-a-slash-11 Medical Device Alert
06 Mar 2026 MHRA
Field Safety Notices: 23-27 February 2026
field-safety-notices-23-27-february-2026 Medical Device Alert
03 Mar 2026 MHRA
MHRA Safety Roundup: February 2026
mhra-safety-roundup-february-2026 Medical Device Alert
25 Feb 2026 MHRA
Class 4 Medicines Defect Notification: Rayner Pharmaceuticals Limited, Dropodex 0.1% w/v Eye Drops, solution, EL(26)A/10
class-4-medicines-defect-notification-rayner-pharmaceuticals-limited-dropodex-0-dot-1-percent-w-slas Medical Device Alert
24 Feb 2026 MHRA
Field Safety Notices: 16-20 February 2026
field-safety-notices-16-20-february-2026 Medical Device Alert
24 Feb 2026 MHRA
Falsified Mounjaro KwikPen 15mg pre-filled pens
falsified-mounjaro-kwikpen-15mg-pre-filled-pens Drug Safety
24 Feb 2026 MHRA
Class 2 Medicines Recall: Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515), KidNaps (Melatonin) 1mg in 1ml…
class-2-medicines-recall-sterling-pharmaceuticals-ltd-specials-manufacturer-ms-32515-kidnaps-melaton Medical Device Alert
23 Feb 2026 MHRA
Class 3 Medicines Recall: Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g, EL(26)A/08
class-3-medicines-recall-norgine-limited-movicol-ease-citrus-powder-for-oral-solution-13-dot-7-g-el- Medical Device Alert
17 Feb 2026 MHRA
Field Safety Notices: 09-13 February 2026
field-safety-notices-09-13-february-2026 Medical Device Alert
17 Feb 2026 MHRA
IXCHIQ Chikungunya vaccine: updates to restrictions of use following safety review
ixchiq-chikungunya-vaccine-updates-to-restrictions-of-use-following-safety-review Drug Safety
11 Feb 2026 MHRA
IXCHIQ Chikungunya vaccine: temporary suspension in people aged 65 years or older
ixchiq-chikungunya-vaccine-temporary-suspension-in-people-aged-65-years-or-older Drug Safety
11 Feb 2026 MHRA
Field Safety Notices: 02-06 February 2026
field-safety-notices-02-06-february-2026 Medical Device Alert
10 Feb 2026 MHRA
Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
semaglutide-wegovy-ozempic-and-rybelsus-risk-of-non-arteritic-anterior-ischemic-optic-neuropathy-nai Drug Safety
05 Feb 2026 MHRA
Class 3 Medicines Recall: Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets, EL(26)A/07
class-3-medicines-recall-aspar-pharmaceuticals-ltd-ibuprofen-200mg-tablets-ibucalm-200mg-tablets-el- Medical Device Alert
04 Feb 2026 MHRA
Class 2 Medicines Recall: Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution, EL(26)A/06
class-2-medicines-recall-syri-limited-t-slash-a-syrimed-baclofen-10mg-slash-5ml-oral-solution-el-26- Medical Device Alert
03 Feb 2026 MHRA
Field Safety Notices: 26 to 30 January 2026
field-safety-notices-26-30-january-2026 Medical Device Alert
02 Feb 2026 MHRA
Class 2 Medicines Recall: Accord Healthcare Ltd, Carmustine 100 mg Powder and Solvent for Concentrate for Solution for …
class-2-medicines-recall-accord-healthcare-ltd-carmustine-100-mg-powder-and-solvent-for-concentrate- Medical Device Alert
02 Feb 2026 MHRA
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed …
national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-quetiapine-oral-suspen Medical Device Alert
29 Jan 2026 MHRA
GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including ne…
glp-1-receptor-agonists-and-dual-glp-1-slash-gip-receptor-agonists-strengthened-warnings-on-acute-pa Drug Safety
29 Jan 2026 MHRA
Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26…
class-4-medicines-defect-notification-viatris-products-ltd-arixtra-solution-for-injection-pre-filled Medical Device Alert
28 Jan 2026 MHRA
Field Safety Notices: 19 to 23 January 2026
field-safety-notices-19-to-23-january-2026 Medical Device Alert
27 Jan 2026 MHRA
Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w, EL(26)A/03
class-4-medicines-defect-notification-blumont-pharma-limited-ocumont-eye-ointment-1-percent-w-slash- Medical Device Alert
27 Jan 2026 MHRA
MHRA Safety Roundup: January 2026
mhra-safety-roundup-january-2026 Medical Device Alert
27 Jan 2026 MHRA
Field Safety Notices: 12 to 16 January 2026
field-safety-notices-12-to-16-january-2026 Medical Device Alert
22 Jan 2026 MHRA
Isotretinoin – changes to prescribing guidance and additional risk minimisation measures
isotretinoin-changes-to-prescribing-guidance-and-additional-risk-minimisation-measures Drug Safety
22 Jan 2026 MHRA
Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg Hard Capsules, EL(26)A/02
class-3-medicines-recall-glenmark-pharmaceuticals-europe-limited-fingolimod-glenmark-0-dot-5-mg-hard Medical Device Alert
21 Jan 2026 MHRA
Class 2 Medicines Recall: Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for inj…
class-2-medicines-recall-mercury-pharmaceuticals-ltd-paliperidone-mercury-pharma-prolonged-release-s Medical Device Alert
20 Jan 2026 MHRA
M6-C Artificial Cervical Disc, Spinal Kinetics LLC: New monitoring requirements for the risk of osteolysis (DSI/2026/00…
m6-c-artificial-cervical-disc-spinal-kinetics-llc-new-monitoring-requirements-for-the-risk-of-osteol Medical Device Alert
15 Jan 2026 MHRA
Field Safety Notices for 05-09 January 2026
field-safety-notices-for-05-09-january-2026 Medical Device Alert
12 Jan 2026 MHRA
Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs
improving-information-supplied-with-gabapentinoids-pregabalin-slash-gabapentin-benzodiazepines-and-z Drug Safety
08 Jan 2026 MHRA
Field Safety Notices: 29 December 2025 to 2 January 2026
field-safety-notices-29-december-2025-to-2-january-2026 Medical Device Alert
07 Jan 2026 MHRA
Field Safety Notices: 22-26 December 2025
field-safety-notices-22-26-december-2025 Medical Device Alert
30 Dec 2025 MHRA
Field Safety Notices: 15 - 19 December 2025
field-safety-notices-15-19-december-2025 Medical Device Alert
22 Dec 2025 MHRA
MHRA Safety Roundup: December 2025
mhra-safety-roundup-december-2025 Medical Device Alert
18 Dec 2025 MHRA
Rybelsus ® (semaglutide tablets): transition to new formulation and risk of medication error
rybelsus-r-semaglutide-tablets-transition-to-new-formulation-and-risk-of-medication-error Drug Safety
17 Dec 2025 MHRA
Class 3 Medicines Recall: Activase Pharmaceuticals Limited, Prednisolone 5mg Soluble Tablets, EL(25)A/54
class-3-medicines-recall-activase-pharmaceuticals-limited-prednisolone-5mg-soluble-tablets-el-25-a-s Medical Device Alert
15 Dec 2025 MHRA